Experimental Brain Research

, Volume 179, Issue 4, pp 655–664

Placebo analgesia: a PET study

  • Hidenori Nemoto
  • Yuki Nemoto
  • Hikaru Toda
  • Masahiko Mikuni
  • Hidenao Fukuyama
Research Article

Abstract

Placebo analgesia involves complex mechanisms and sometimes has a marked effect on patients in pain. In this study we examined changes in regional cerebral blood flow (rCBF) under three different conditions (resting, hot, painful) before and after placebo administration using H215O and positron emission tomography in ten healthy subjects. In five subjects, placebo administration significantly decreased pain-intensity score (placebo responders), and rCBF in the medial prefrontal cortex (MPFC), posterior parietal cortex (PPC), and inferior parietal lobe (IPL) increased after placebo administration compared with before placebo administration under the painful condition. Furthermore, in the placebo responders, rCBF in the MPFC, PPC and IPL also increased under the resting condition (without sensory stimulation) after placebo administration compared with before placebo administration. However, there was no rCBF change under the rest condition in the placebo nonresponders after placebo administration. These results suggest that placebo analgesia has its effect under the resting condition and MPFC, IPL and PPC may have an important role in placebo analgesia.

Keywords

Placebo analgesia Positron emission tomography Regional cerebral blood flow Psychological effect 

References

  1. Adler LJ, Gyulai FE, Diehl DJ, Mintun MA, Winter PM et al (1997) Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography. Anesth Analg 84:120–126PubMedCrossRefGoogle Scholar
  2. Damasio AR, Grabowski TJ, Bechara A, Damasio H, Ponto LLB, Parvizi J, Hichwa RD (2000) Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 3:1049–1056PubMedCrossRefGoogle Scholar
  3. Derbyshire SWG, Jones AKP (1998) Cerebral responses to a tonic pain stimulus measured using positron emission tomography. Pain 76:127–135PubMedCrossRefGoogle Scholar
  4. Eisenberger NI, Lieberman MD, Williams KD (2003) Does rejection hurt? An fMRI study of social exclusion. Science 302:290–292PubMedCrossRefGoogle Scholar
  5. Fields HL, Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R (Eds) Textbook of pain. Churchill Livingstone, Edinburgh, pp 309–323Google Scholar
  6. Lane RD, Fink GR, Chau PM, Dolan RJ (1997a) Neural activation during selective attention to subjective emotional responses. Neuroreport 8:3969–3972CrossRefGoogle Scholar
  7. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ (1997b) Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry 154:926–933Google Scholar
  8. Lui S, Kopacz DJ, Carpenter RL (1995) Quantitative assessment of differential sensory nerve block after lidocaine spinal anesthesia. Anesthesiology 82:60–63CrossRefGoogle Scholar
  9. Nemoto H, Toda H, Nakajima T, Hosokawa S, Okada Y, Yamamoto K, Horiuchi R, Endo K, Ida I, Mikuni M, Goto F (2003) Fluvoxamine modulates pain sensation and affective processing of pain in human brain. Neuroreport 14:971–977CrossRefGoogle Scholar
  10. Petrovic P, Kalso E, Petersson KM, Invar M (2002) Placebo and opioid analgesia-imaging a shared neuronal network. Science 295:1737–1740PubMedCrossRefGoogle Scholar
  11. Phan KL, Wager T, Taylor SF, Liberzon I (2002) Functional neuroanatomy of emotion: a meta-analysis of emotion activated studies in PET and fMRI. Neuroimage 16:331–348PubMedCrossRefGoogle Scholar
  12. Price DD (Ed) (1999) Psychological mechanisms of pain and analgesia. IASP Press, SeattleGoogle Scholar
  13. Rainville P (2002) Brain mechanisms of pain affect and pain modulation. Curr Opin Neurobiol 12:195–204PubMedCrossRefGoogle Scholar
  14. Singer T, Seymour B, O’Doherty J, Kaube H, Dolan RJ, Frith CD (2004) Empathy for pain involves the affectve but not sensory components of pain. Science 303:1157–1162PubMedCrossRefGoogle Scholar
  15. Treede RD, Kenshalo DR, Gracely RH, Jones AKP (1999) The cortical representation of pain. Pain 79:105–111PubMedCrossRefGoogle Scholar
  16. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O (2002) Automated anatomical labeling of activation in SPM using a macroscopic anatomical parcellation of the MNI NRI single-subject brain. Neuroimage 15:273–289PubMedCrossRefGoogle Scholar
  17. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD (2004) Placebo-induced changes in fMRI in the anticipation and expectation of pain. Science 303:1162–1167PubMedCrossRefGoogle Scholar
  18. Zubieta JK, Smith YP, Bueller JA, Xu Y, Kilbourn MR (2001) Regional Mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293:311–315PubMedCrossRefGoogle Scholar
  19. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS (2005) Placebo effects mediated by endogenous opioid activity on myu-opioid receptors. J Neurosci 25:7754–7762PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Hidenori Nemoto
    • 1
  • Yuki Nemoto
    • 1
  • Hikaru Toda
    • 2
  • Masahiko Mikuni
    • 3
  • Hidenao Fukuyama
    • 4
  1. 1.Department of AnesthesiologyMito Red Cross HospitalMitoJapan
  2. 2.Department of AnesthesiologySaitama Cancer CenterKitaadachi-gunJapan
  3. 3.Department of Neuropsychiatry and Human BehaviorGunma UniversityMaebashiJapan
  4. 4.Human Brain Research CenterKyoto University Graduate School of MedicineKyotoJapan

Personalised recommendations